Analysts Set Colgate-Palmolive (NYSE:CL) Price Target at $101.16

Colgate-Palmolive (NYSE:CL) has been assigned a consensus rating of “Moderate Buy” from the twenty-two ratings firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and twelve have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $101.16.

CL has been the topic of several analyst reports. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $101.00 price target on shares of Colgate-Palmolive in a report on Wednesday, January 29th. Barclays reduced their price objective on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday, January 17th. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Finally, UBS Group reduced their price objective on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a research report on Monday, February 3rd.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $85.94 on Thursday. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. Colgate-Palmolive has a 1-year low of $82.68 and a 1-year high of $109.30. The company has a market capitalization of $70.21 billion, a P/E ratio of 24.41, a P/E/G ratio of 4.12 and a beta of 0.44. The firm’s 50 day simple moving average is $90.36 and its two-hundred day simple moving average is $96.77.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the company earned $0.87 EPS. Research analysts expect that Colgate-Palmolive will post 3.73 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.33%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is 56.82%.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of CL. Generali Asset Management SPA SGR purchased a new stake in shares of Colgate-Palmolive during the fourth quarter valued at $8,105,000. Mirova US LLC boosted its stake in shares of Colgate-Palmolive by 16.3% during the fourth quarter. Mirova US LLC now owns 11,849 shares of the company’s stock valued at $1,077,000 after purchasing an additional 1,659 shares during the period. Horizon Investments LLC boosted its stake in shares of Colgate-Palmolive by 1.3% during the fourth quarter. Horizon Investments LLC now owns 12,390 shares of the company’s stock valued at $1,120,000 after purchasing an additional 165 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of Colgate-Palmolive by 22.1% during the fourth quarter. Advisors Asset Management Inc. now owns 78,474 shares of the company’s stock valued at $7,134,000 after purchasing an additional 14,210 shares during the period. Finally, Mystic Asset Management Inc. boosted its stake in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Mystic Asset Management Inc. now owns 24,135 shares of the company’s stock valued at $2,194,000 after purchasing an additional 1,038 shares during the period. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.